Home Breast cancer and pregnancy
Article
Licensed
Unlicensed Requires Authentication

Breast cancer and pregnancy

  • Laura Knabben EMAIL logo and Michel D. Mueller
Published/Copyright: August 29, 2017

Abstract

Background

In the past decades the incidence of pregnancy-associated breast cancer (PABC) increased. Possible explanations are the trend to postpone childbearing and the general increase in the incidence of breast cancer.

Materials and methods

A sytematic review of the literature was performed with the aim to report on incidence, diagnosis, treatment and prognosis of breast cancer during pregnancy. We also cover the issue of pregnancy following a diagnosis of breast cancer including fertility preservation and prognosis.

Results

Ultrasound is the imaging method of choice in pregnancy, but mammography can also be performed as the fetal irradiation dose is low. To avoid a delay in diagnosis every sonographic mass in pregnant women which does not clearly correspond to a cyst needs further investigation by biopsy. Treatment should follow as close as possible the guidelines for non-pregnant patients. Administration of chemotherapy is possible after the first trimester. There is a large body of evidence for the use of anthracyclines. In contrast radiotherapy, trastuzumab and antihormonal treatment by tamoxifen are contraindicated during pregnancy. Pregnancy does not seem to influence prognosis. Most adverse obstetric outcomes are related to preterm delivery, which should therefore, whenever possible, be avoided. Young patients with breast cancer and incomplete family planning should be referred for counseling about fertility preservation options before the initiation of adjuvant treatment. A pregnancy following breast cancer does not have a negative impact on prognosis.

Conclusion

Multidisciplinary management of women with breast cancer in pregnancy is mandatory and data should be collected to allow further improvement in management.

Author Statement

  1. Research funding: Authors state no funding involved.

  2. Conflict of interest: Authors state no conflict of interest.

  3. Informed consent: Informed consent is not applicable.

  4. Ethical approval: The conducted research is not related to either human or animals use.

References

[1] AnderssonTM, JohanssonAL, HsiehCC, CnattingiusS, LambeM. Increasing incidence of pregnancy-associated breast cancer in Sweden. ObstetGynecol. 2009;114:56872.10.1097/AOG.0b013e3181b19154Search in Google Scholar

[2] AnderssonTM, JohanssonAL, FredrikssonI, LambeM. Cancer during pregnancy and the postpartum period: a population-based study. Cancer. 2015;121:20727.10.1002/cncr.29325Search in Google Scholar

[3] CsonkaY, MosimannA. Familien in der Schweiz – Statistischer Bericht 2017. Neuchâtel: Swiss Federal Statistical Office (Bundesamt für Statistik), 2017.Search in Google Scholar

[4] BonnierP, RomainS, DilhuydyJM, BonichonF, JulienJP, CharpinC, et al.Influence of pregnancy on the outcome of breast cancer: a case-control study. Int J Cancer. 1997;72:7207.10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-USearch in Google Scholar

[5] CordobaO, LlurbaE, SauraC, RubioI, FerrerQ, CortésJ, et al.Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes. Breast. 2013;22:5159.10.1016/j.breast.2012.10.005Search in Google Scholar

[6] TaylorD, LazbergerJ, IvesA, WylieE, SaundersC. Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol. 2011;55:3342.10.1111/j.1754-9485.2010.02227.xSearch in Google Scholar

[7] MiddletonLP, AminM, GwynK, TheriaultR, SahinA. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98:105560.10.1002/cncr.11614Search in Google Scholar

[8] DominiciLS, KuererHM, BabieraG, HahnKM, PerkinsG, MiddletonL, et al.Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010;31:15.10.3233/BD-2009-0289Search in Google Scholar

[9] LohsiriwatV, PeccatoriFA, MartellaS, AzimHA, SarnoMA, GalimbertiV, et al.Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast. 2013;22:65760.10.1016/j.breast.2013.06.005Search in Google Scholar

[10] SpanheimerPM, GrahamMM, SuggSL, Scott-ConnerCE, WeigelRJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann SurgOncol. 2009;16:11437.10.1245/s10434-009-0390-zSearch in Google Scholar

[11] GropperAB, CalvilloKZ, DominiciL, TroyanS, RheiE, EconomyKE, et al.Sentinel lymph node biopsy in pregnant women with breast cancer. Ann SurgOncol. 2014;21:250611.10.1245/s10434-014-3718-2Search in Google Scholar

[12] BerryDL, TheriaultRL, HolmesFA, ParisiVM, BooserDJ, SingletarySE, et al.Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:85561.10.1200/JCO.1999.17.3.855Search in Google Scholar

[13] RingAE, SmithIE, JonesA, ShannonC, GalaniE, EllisPA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five Londonteaching hospitals. J Clin Oncol. 2005;23:41927.10.1200/JCO.2005.03.038Search in Google Scholar

[14] HahnKM, JohnsonPH, GordonN, KuererH, MiddletonL, RamirezM, et al.Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:121926.10.1002/cncr.22081Search in Google Scholar

[15] CardonickE, DoughertyR, GranaG, GilmandyarD, GhaffarS, UsmaniA. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16:7682.10.1097/PPO.0b013e3181ce46f9Search in Google Scholar

[16] LoiblS, HanSN, von MinckwitzG, BontenbalM, RingA, GiermekJ, et al.Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13:88796.10.1016/S1470-2045(12)70261-9Search in Google Scholar

[17] ZagouriF, SergentanisTN, ChrysikosD, DimitrakakisC, TsigginouA, ZografosCG, et al.Taxanes for breast cancer during pregnancy: a systematic review. Clin Breast Cancer. 2013;13:1623.10.1016/j.clbc.2012.09.014Search in Google Scholar PubMed

[18] LoiblS, SchmidtA, GentiliniO, KaufmanB, KuhlC, DenkertC, et al.Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1:114553.10.1001/jamaoncol.2015.2413Search in Google Scholar PubMed

[19] ZagouriF, SergentanisTN, ChrysikosD, PapadimitriouCA, DimopoulosMA, BartschR. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137:34957.10.1007/s10549-012-2368-ySearch in Google Scholar PubMed

[20] AzimHA, Metzger-FilhoO, de AzambujaE, LoiblS, FocantF, GreskoE, et al.Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01 - 01). Breast Cancer Res Treat. 2012;133:38791.10.1007/s10549-012-1996-6Search in Google Scholar PubMed

[21] CullinsSL, PridjianG, SutherlandCM. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. J Am Med Assoc. 1994;271:19056.10.1001/jama.1994.03510480029019Search in Google Scholar

[22] TewariK, BonebrakeRG, AsratT, ShanbergAM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet. 1997;350:183.10.1016/S0140-6736(97)24029-8Search in Google Scholar

[23] StovallM, BlackwellCR, CundiffJ, NovackDH, PaltaJR, WagnerLK, et al.Fetal dose from radiotherapy with photon beams: report of AAPM radiation therapy committee task group no. 36. Med Phys. 1995;22:6382.10.1118/1.597525Search in Google Scholar PubMed

[24] LuisSA, ChristieDR, KaminskiA, KennyL, PeresMH. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol. 2009;53:55968.10.1111/j.1754-9485.2009.02124.xSearch in Google Scholar PubMed

[25] AmantF, von MinckwitzG, HanSN, BontenbalM, RingAE, GiermekJ, et al.Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31:25329.10.1200/JCO.2012.45.6335Search in Google Scholar PubMed

[26] Van CalsterenK, HeynsL, De SmetF, Van EyckenL, GziriMM, Van GemertW, et al.Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28:6839.10.1200/JCO.2009.23.2801Search in Google Scholar PubMed

[27] GoldfarbSB, KamerSA, OppongBA, EatonA, PatilS, JunqueiraMJ, et al.Fertility preservation for the young breast cancer patient. Ann SurgOncol. 2016;23(5):15306.10.1245/s10434-015-5036-8Search in Google Scholar PubMed PubMed Central

[28] SukumvanichP, CaseLD, Van ZeeK, SingletarySE, PaskettED, PetrekJA, et al.Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer. 2010;116:310211.10.1002/cncr.25106Search in Google Scholar PubMed

[29] AndersonRA, ThemmenAP, Al-QahtaniA, GroomeNP, CameronDA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006;21:258392.10.1093/humrep/del201Search in Google Scholar PubMed

[30] MarguliesAL, SelleretL, ZilbermanS, NargarraIT, ChopierJ, GligorovJ, et al.Pregnancy after cancer: for whom and when?. Bull Cancer. 2015;102:4639.10.1016/j.bulcan.2015.03.012Search in Google Scholar PubMed

[31] AzimHA, SantoroL, PavlidisN, GelberS, KromanN, AzimH, et al.Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47:7483.10.1016/j.ejca.2010.09.007Search in Google Scholar PubMed

[32] AzimHA, BellettiniG, LiptrottSJ, ArmeniME, Dell’AcquaV, TortiF, et al.Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast. 2010;19:52731.10.1016/j.breast.2010.05.018Search in Google Scholar PubMed

Received: 2017-5-2
Accepted: 2017-7-17
Published Online: 2017-8-29

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 24.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2017-0026/html
Scroll to top button